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Abstract
Gastrointestinal cancer patients were followed up for up to 30 months postoperatively and
their clinical status related to a parameter of nonspecific immunity, the blastformation rate of pe-
ripheral blood lymphocytes against phytohemagglutinin. By the fourth postoperative week, the
blastformation rate had recovered from the effect of the operation. In patients who had undergone
curative resection, the postoperative level rose to exceed the preoperative level, whereas whereas
in those in whom resection had not been possible, the blastformation rate failed to show this rise
by the fourth week, and continued at the decreased immediate postoperative level. Results for
long-term follow-up (30 months postoperatively) showed that the blastformation rate continued at
high levels (almost all over 40%) in cases of curative resection without recurrence, but remained
low (under 40%) in those in which the tumor could not be removed. The 40% level of the blastfor-
mation rate test thus correlated well with the prognosis. The blastformation rate, therefore, proved
a very good parameter for following the pre-and post-operative clinical course of gastrointestinal
cancer patients.
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Ahstract. Gastrointestinal cancer patients were followed up for
up to 30 months postoperatively and their clinical status related to a
parameter of nonspecific immunity, the blastformation rate of peri-
pheral blood lymphocytes against phytohemagglutinin. By the fourth
postoperative week, the blastformation rate had recovered from the
effect of the operation. In patients who had undergone curative resec-
tion, the postoperative level rose to exceed the preoperative level,
whereas in those in whom resection had not been possible, the blast-
formation rate failed to show this rise by the fourth week, and con-
tinued at the decreased immediate postoperative level. Results for
long-term follow-up (30 months postoperatively) showed that the blast-
formation rate continued at high levels (almost all over 40%) in cases
of curative resection without recurrence, but remained low (under
40%) in those in which the tumor could not be removed. The 40%
level of the blastformation rate test thus correlated well with the
prognosis. The blastformation rate, therefore, proved a very good
parameter for following the pre- and post-operative clinical course of
gastrointestinal cancer patients.
Decreases in specific and non-specific cell-mediated immunity. have been
demonstrated in gastrointestinal cancer as well as in other types of malignant
tumors. A nonspecific cell-mediated immune reaction, the blastformation rate of
peripheral blood lymphocytes against phytohemagglutinin (PHA) has been re-
ported to decrease in nonlymphoid malignancies (I) but this is still debated (2).
Previously, we reported the use of non-specific tests of cell-mediated immunity in
gastrointestinal cancer patients as a preoperative parameter for assessing the
extent of cancer progress (3, 4). The blastformation rate of peripheral blood
lymphocytes proved effective for such assessment and was useful in deciding
whether or not curative resection was possible. The present paper continues this
study and relates postoperative changes in the lymphocyte blastformation rate
with the clinical condition of gastrointestinal cancer patients.
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MATERIALS AND METHODS
Subjects. Gastrointestinal cancer patients in whom adequate investigation
of the blastformation rate both before and after operation had been possible
were grouped into three surgical classes: curative resection, noncurative re-
section and nonresection. Patients over 70 years of age (in whom cell-mediated
immunity is low (5)), recurrent cases, and nonoperated cases were omitted from
the present study.
Methods. Blastformation tests were performed with 5 ml of heparinized
peripheral blood using the authors' standard technique (6).
RESULTS
Changes in the blastformation rate before and after operation. Figure la shows
the results for blastformation rates before, and up to one month after, operation.
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Fig. 1. Fluctuations of blastformation rate before and after
operation. • , curative resection; 4., noncurative
resection; X······ X, nonresection
In the curative resection group, the blastformation rates before operation and
weekly thereafter (to the fourthpostoperation week) were48.5±15.8%, 38.6±
13.4% (0.05<p<0.1), 38.1±17.3% (0.01<p<0.05), 39.8±13.4% (0.02<
p< 0.05), and 49.2 ± 14.1 % (p >0.5), respectively. The blastformation rate in
most of cases fell during the first three weeks postoperatively, but had recovered
by the fourth postoperative week. The blastformation rate by the fourth week
had not only regained the pre-operative level, but often exceeded it. In the non-
curative resection group, and also in the non-resection group, the postoperative
blastformation rate showed no recovery from the preoperative blastformation
rate and was still low at the fourth week postoperatively. The proportion of
patients having blastformation rates over 40 % decreased postoperatively, but
had begun to increase by the fourth week postoperatively (Fig. 1b). In conjunc-
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tion with the similar pattern of fall and rise of the blastformation rate, this
indicates that the direct effects of undergoing surgery had been overcome by the
fourth postoperative week.
The two groups of curative resection and nonresection were then compared
by taking an arbitrary level of 40% for the blastformation test. There were 91
cases of curative resection. Sixty-one of these had preoperative blastformation
rates: over 40% and this level was still being maintained in 53 of them (86.9%)
one month after operation. Of the remaining 30 cases with preoperative blast-
formation rates under 40%, 18 (40%) had rates over 40% by one month after
operation. Overall, those with blastformation rates over 40 % in this group
were 67% of cases preoperatively, and 78% by one month postoperatively
(Table 1).
TABLE 1. FLUCTUATIONS OF BLASTFORMATION RATE BEFORE AND AFTER
CURATIVE RESECTION IN CANCER PATIENTS
----.~--------
Before
operation
+
+
One month after
operatiou
+
+
No. of
cases
53
8
18
12
91
%
58.2
8.8
19.8
13.2
100.0
+ : Blastformation rate of over 40%
- : Blastformation rate of under 40%
There were 46 patients in the nonresection group. Of these 76.1 % had
blastformation rates less than 40% before operation, but the number of those
with rates less than 40% had increased to 84.8% by one month after operation
(Table 2). This difference in the blastformation rates for curative rese~tion and
TABLE 2. FLUCTUATIONS OF BLASTFORMATION RATE BEFORE AND AFTER
OPERATION IN CASES NOT UNDERGOING CANCER EXTIRPATION
Before
operation
+
+
One month after
operation
+
+
No. of
cases
3
8
4
31
46
%
6.5
17.4
8.7
67.4
100.0
+ : Blastformation rate of over 40%
- : Blastformation rate of under 40%
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nonrescction was extremely important clinically since the cases of curative re-
section with blastformation rates over 40% continued to have a favorable clinical
course. This was probably due to recovery of following complete tumor extirpa-
tion.
Changes in postoperative blast/ormation rates in the long-term. In both the
curative resection and the nonresection groups, the bhstformation rate was fol-
lowed for up to a period of two and a half years postoperatively. Tests were
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Fig. 2. Fluctuations of blastformation rat: after curative resection.
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Fig. 3. Fluctuations of blastformation rate after nonresectable operation.
4
Acta Medica Okayama, Vol. 31 [1977], Iss. 5, Art. 6
http://escholarship.lib.okayama-u.ac.jp/amo/vol31/iss5/6
Postoperative Blastogenesis in Cancer 335
repeated when any sudden fall in the blastformation rate was encountered. In
the 91 cases of curative resection, the majority had blastformation rates over
40% a short time after the operation (by the fourth week). A few exceptions
occurred who continued to have low blastformation rates «40%) by the eighth
postoperative month not related to recurrence of the cancer. However, the
blastformation rates had all risen to over 40% by the end of the first year (Fig. 2).
The 51 patients in whom the tumor was not removed continued to have low
blastformation rates «40 %) until their death (Fig. 3).
DISCUSSION
The use of immunological monitoring in various clinical conditions is be-
coming well-established. At present, such monitoring is based on parameters of
cell-mediated immunity. These parameters consist of specific immune tests
based on the interaction of the host's lymphocytes with cancer and on non-
specific immune tests which only assess the non-specific immunocapacity of the
host. The blastformation rate to PHA is a representative non-specific immune
test and has already been reported as giving a good indication of the extent
of cancer and the feasibility of curative resection (3, 4). Parameters of both
specific and non-specific cell-mediated immunity are also being used for assessing
the results of cancer immunotherapy (e.g., BeG) but as yet, there has been non
authorative statement as to which type of parameter is most reliable.
To be reliable, the test of cell-mediated immunity should reflect the clinical
status of the cancer-bearing patient before and after operation. We investigated
whether the blastformation rate satisfies such requirements.
Figure 1 illustrates the effects of operation and anesthesia up to the fourth
postoperative week as shown by the blastformation rate. The rate fell from the
first week to the third week postoperatively, then recovered by the fourth post-
operative week to regain the preoperative level. Similar results have been re-
ported by Riddle and Berenbaum (7).
In the curative resection cases, the fact that blastformation rates after
operation were higher than before operation indicates that the host immunity is
restored by tumor extirpation. Those not undergoing tumor extirpation had low
blastformation rates, a reflection of their loss of immunity. Similar results have
been reported using macrophage migration inhibition tests (MIT) (8).
Long-term observation of the patient post-operatively (30 months) indicated
that patients having a blastformation rate over 40 % before operation had a
favorable prognosis (Fig. 2). In patients without a recurrence, the blastformation
rate postoperatively remained above 40 % in the majority of cases, whereas the
rate was persistently low for the nonresection group. The 40% blastformation
rate did, therefore, serve as a useful boundary line for distinguishing between
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these two groups. This supports our early work on the potential usefulness of the
preoperative blastformation rate as a prognostic aid (9).
In patients with a recurrence during the postoperative course, the blastfor-
mation rate rose slightly three to four months before confirmation of the recur-
rence, then fell rapidly during the remaining two months before clinical confir-
mation (10). This characteristic pattern indicates that the blastformation test
may also be very useful in the diagnosis of a recurrence. There are very few
reports of long term postoperative monitoring of blastformation rates, so this
possibility awaits verification.
The correlation between immunological tests and the prognosis in cancer
patients has also been studied by Pinsky (11) and Morton et al (12). They stated
that a preoperative DNCB test alone correlated well with recurrence at six
months postoperatively, and also with the long-term prognosis (up to two years).
Krant et al (13) reported that patients with positive PPD tests had good prognoses,
whereas in those in whom the PPD test turned negative, the prognosis was un-
favorable. Orita et al (14) used MIF tests to follow the results of immunotherapy
in patients immunized with BCG-CWS (cell wall skeleton). They reported that
this test both reflected well the postoperative course of cancer patients and served
as a useful parameter of the ~ffect of immunotherapy.
Although both specific and nonspecific immune tests reflect well the prog-
nosis of cancer patients, nonspecific immune tests do not require cancer tissue for
the test. They are, therefore, easily performed and useful as a parameter in anti-
cancer therapy (15), irradiation therapy (16), and when using immune potentia-
tors (17). Moreover, it is possible to monitor cancer patients postoperatively
over an extremely long period of time. They are, therefore, recommended as an
excellent clinical aid.
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